The epidemiology and prevalence of Ulcerative colitis in the South of India


Ulcerative colitis is considered frequent in majority of European and North American population and exceptional in most of the developing Asian countries. There is a dearth of reported data from South India on the incidence of the disease and its prevalence. Hence the present study was designed to estimate the prevalence of ulcerative colitis in a tertiary care hospital of Hyderabad, South India. The study population consisted of 157 Ulcerative colitis and 204 healthy subjects. All subjects were interviewed by means of a questionnaire for general demographical details and socioeconomic conditions, health related quality of life and history of UC. Patients were categorized based on disease severity; moderate: 95, and severe: 62 and disease manifestation: 73 (46.5%) pancolitis, 60 (38.2%) left-sided colitis and 24 (15.3%) had proctosigmoiditits. Disease prevalence was high in patients of <35 years age. Junk/outside food consumers were significantly high in Ulcerative colitis than controls 68 (43.3%) vs 67 (32.8%) p = 0.048. There was no significant difference of disease prevalence with diet, drinking habits and alcoholic consumption. Whereas UC prevalence was high in nonsmokers than smokers (p = 0.025). This report establishes the importance of various factors in ulcerative colitis. This is the first population based study from South India that reports the prevalence of ulcerative colitis. Ulcerative colitis is more predominant in young age. Further, junk food consumers and Non-smokers/ex-smokers were found to be high in terms of UC prevalence.

Share and Cite:

Gunisetty, S. , Tiwari, S. , Bardia, A. , Phanibhushan, M. , Satti, V. , Habeeb, M. and Khan, A. (2012) The epidemiology and prevalence of Ulcerative colitis in the South of India. Open Journal of Immunology, 2, 144-148. doi: 10.4236/oji.2012.24018.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Danese, S. and Fiocchi, C. (2006) Etiopathogenesis of inflammatory bowel diseases. World Journal of Gastroenterology, 12, 4807-4812.
[2] Peeters, M., Cortot, A., Vermeire, C., et al. (2000) Familial and sporadic inflammatory bowel disease: Different entities. Inflammatory Bowel Diseases, 6, 314-320.
[3] Kefalides, P.T. and Hanauer, S.B. (2002) Ulcerative colitis: Diagnosis and management. Journal of Clinical Outcomes Management, 8, 40-48.
[4] Molinie, F., Gower-Rousseau, C., Yzet, T. et al. (2004) Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988-1999). Gut, 53, 843-848. doi:10.1136/gut.2003.025346
[5] Sincic, B.M., Vucelic, B., Persic, M., et al. (2006) Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study. Scandinavian Journal of Gastroenterology, 41, 437-444. doi:10.1080/00365520500320094
[6] Lakatos, P.L., Fischer, S. and Lakatos, L. (2006) Is the epidemiology of inflammatory bowel disease changing in Eastern Europe? Scandinavian Journal of Gastroenterology, 41, 870-871. doi:10.1080/00365520600636167
[7] Thia, K.T., Loftus Jr, E.V., Sandborn, W.J., et al. (2008) An update on the epidemiology of inflammatory bowel disease in Asia. American Journal of Gastroenterology, 103, 3167-3182. doi:10.1111/j.1572-0241.2008.02158.x
[8] Sood, A., Midha, V., Sood, N., et al. (2003) Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut, 52, 1587-1590. doi:10.1136/gut.52.11.1587
[9] Siew, C.N.(2010) Changing epidemiology and future challenges of inflammatory bowel disease in Asia. Intestinal Research, 8, 1-8. doi:10.5217/ir.2010.8.1.1
[10] Tandon, B.N., Mathus, A.K., Mohapatra, L.N., et al. (1965) A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India. Gut, 6, 448-453. doi:10.1136/gut.6.5.448
[11] Podolsky, D.K. (1991) Inflammatory bowel disease. The New England Journal of Medicine, 325, 928-937. doi:10.1056/NEJM199109263251306
[12] Satsangi, J., Silverberg, M.S., Vermaire, S., et al. (2006) The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut, 55, 749-753. doi:10.1136/gut.2005.082909
[13] Langan, R.C., Gotsch, P.B., Krafczyk, M.A., et al. (2007) Ulcerative colitis: Diagnosis and treatment. American Family Physician, 76, 1323-1330.
[14] Cencic, A. and Chingwaru, W. (2010) The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients, 2, 611-625. doi:10.3390/nu2060611
[15] Marsh, M.N. and Crowe, P.T. (1995) Morphology of the mucosal lesion in gluten sensitivity. Bailliere’s Clinical Gastroenterology, 9, 273-293. doi:10.1016/0950-3528(95)90032-2
[16] Gillberg, R., Dotevall, G. and Ahren, C. (1982) Chronic inflammatory bowel disease in patients with coeliac disease. Scandinavian Journal of Gastroenterology, 17, 491-496. doi:10.3109/00365528209182237
[17] Aamodt, G., Bukholm, G., Jahnsen, J., et al. (2008) The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in Southeastern Norway. American Journal of Epidemiology, 168, 1065-1072. doi:10.1093/aje/kwn218
[18] Bastida, G. and Beltran, B. (2011) Ulcerative colitis in smokers, non-smokers and ex-smokers. World Journal of Gastroenterology, 17, 2740-2747.
[19] Samuelsson, S.M., Ekbom, A., Zack, M., et al. (1991) Risk factors for extensive ulcerative colitis and ulcerative proctitis: A population based case-control study. Gut, 32, 1526-1530. doi:10.1136/gut.32.12.1526
[20] Finnie, I.A., Campbell, B.J., Taylor, B.A., et al. (1996) Stimulation of colonic mucin synthesis by corticosteroids and nicotine. Clinical Science, 91, 359-364.
[21] Swansona, G.R., Sedghib, S., Farhadia, A., et al. (2010) Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol, 44, 223-228. doi:10.1016/j.alcohol.2009.10.019

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.